This high-throughput NGS assay enables labs to detect SARS-CoV-2 mutations to identify and track the emergence and prevalence of novel variants.
COVIDSeq Test (RUO Version) is a next-generation sequencing (NGS) assay that enables researchers to detect and characterize novel variants of SARS-CoV-2.
The Illumina COVIDSeq Test (RUO version) accommodates 384 to 3072 samples, depending on throughput needs.
96 amplicons provide full coverage across SARS-CoV-2 genome for in-depth characterization of new variants.
The kit includes all reagents needed for cDNA conversion, amplification, and library prep. A 63°C annealing temperature during PCR improves variant analysis and insights.
Assess lineage and annotate mutations with open software tools, including the Illumina DRAGEN Microbial Amplicon App in BaseSpace Sequence Hub.
| Automation capability | Liquid handling robot(s) |
|---|---|
| Automation details | Explore available automation methods |
| Content specifications | Whole viral genome coverage including the spike protein locus |
| Description | The COVIDSeq Test (RUO Version) is a scalable high-throughput NGS assay (up to 3072 samples) intended for research applications. |
| Instruments | MiSeq System, iSeq 100 System, NextSeq 550 System, NextSeq 2000 System, NextSeq 1000 System, MiSeqDx in Research Mode, MiniSeq System, NextSeq 550Dx in Research Mode, NovaSeq 6000Dx in Research Mode, NextSeq 500 System, NovaSeq 6000 System |
| Method | Amplicon sequencing, Targeted RNA sequencing |
| Multiplexing | 384-plex on NextSeq 384-plex on NovaSeq |
| Nucleic acid type | RNA |
| Sample type details | Nasopharyngeal, oropharyngeal, mid-turbinate nasal swab, and wastewater samples |
| Species category | Virus |
| Species details | SARS-CoV-2 |
| Strand specificity | Non-stranded |
| Technology | Sequencing |
In addition to the Illumina COVIDSeq Test (3072 samples), you will need:
The COVIDSeq Positive Control is an optional product.
The COVIDSeq Test (RUO Version) is an integrated NGS research solution for detection and characterization of SARS-CoV-2, not for use in diagnostic procedures or patient management.
Illumina COVIDSeq Test (RUO Version)
NGS can identify novel coronavirus variants, track COVID-19 transmission, and more. Compare NGS methods for various coronavirus sequencing goals.
As a hypothesis-free method, NGS can distinguish between infectious disease strains that differ by as little as one SNP, and replace the need for multiple tests.
Host genetics and immune response profiling
Studying host genetic differences and individual immune responses to the SARS-CoV-2 virus can shed light on COVID-19 disease susceptibility and severity.
| COVIDSeq Test (RUO Version) | COVIDSeq Assay (96 samples) | Pan-Coronavirus Panel | Respiratory Pathogen ID/AMR Enrichment Panel Kit | ||
|---|---|---|---|---|---|
| Automation capability | Liquid handling robot(s) | Liquid handling robot(s) | Liquid handling robot(s) | Liquid handling robot(s) | |
| Automation details | Explore available automation methods | Explore available automation methods | Explore available automation methods | ||
| Content specifications | Whole viral genome coverage including the spike protein locus | Whole viral genome coverage including the spike protein locus | Detects respiratory pathogen DNA and RNA simultaneously and profiles antimicrobial resistance (AMR) gene expression concurrently. | ||
| Description | The COVIDSeq Test (RUO Version) is a scalable high-throughput NGS assay (up to 3072 samples) intended for research applications. | The COVIDSeq Assay (96 samples) is a low- to mid-throughput NGS assay intended to be processed on any Illumina benchtop sequencing system for research applications. | The Pan-Coronavirus Panel is part of an integrated workflow that allows for the detection and whole-genome sequencing of over 200 known and novel coronavirus strains in various animal hosts. | Identify respiratory infections and co-infections, detect antimicrobial resistance markers, and perform strain typing of critical pathogens (SARS-CoV-2 and Flu A/B viruses) to study viral evolution and transmission. | |
| Instruments | MiSeq System, iSeq 100 System, NextSeq 550 System, NextSeq 2000 System, NextSeq 1000 System, MiSeqDx in Research Mode, MiniSeq System, NextSeq 550Dx in Research Mode, NovaSeq 6000Dx in Research Mode, NextSeq 500 System, NovaSeq 6000 System | MiSeq System, iSeq 100 System, NextSeq 550 System, NextSeq 2000 System, NextSeq 1000 System, MiSeqDx in Research Mode, MiniSeq System, NextSeq 550Dx in Research Mode, NovaSeq 6000Dx in Research Mode, NextSeq 500 System, NovaSeq 6000 System | MiSeq System, NextSeq 550 System, NextSeq 2000 System, NextSeq 1000 System, MiniSeq System | MiSeq System, NextSeq 550 System, MiniSeq System | |
| Method | Amplicon sequencing, Targeted RNA sequencing | Amplicon sequencing, Targeted RNA sequencing | Whole-genome sequencing, Target enrichment | Targeted DNA sequencing, Targeted RNA sequencing, Target enrichment | |
| Multiplexing | 384-plex on NextSeq 384-plex on NovaSeq | 8-plex on the iSeq System 30–48 plex on the MiSeq System 48-plex on the MiniSeq System | Up to 384 samples in a single run with unique dual indexes | Up to 384 samples in a single run with unique dual indexes | |
| Nucleic acid type | RNA | RNA | RNA | DNA, RNA | |
| Sample type details | Nasopharyngeal, oropharyngeal, mid-turbinate nasal swab, and wastewater samples | Nasopharyngeal, oropharyngeal, mid-turbinate nasal swab, and wastewater samples | |||
| Species category | Virus | Virus | Virus | Fungal, Virus, Bacteria | |
| Species details | SARS-CoV-2 | SARS-CoV-2 | Detects respiratory pathogens (180+ bacteria, 50+ fungi, and 40+ viruses, including SARS-CoV-2) and antimicrobial resistance alleles (1200+). | ||
| Strand specificity | Non-stranded | Non-stranded | Non-stranded | ||
| Technology | Sequencing | Sequencing | Sequencing | Sequencing |
Library Prep and Array Kit Selector
Find the right sequencing library preparation kit or microarray for your needs. Filter by method, species, and more. Compare, share, and order kits.
Heat map plotting performance as a function of read length and depth shows significant improvement with paired-end reads over single reads. The fraction of genomes > 0.99 confident is shown, with values close to 1 representing more complete coverage of the SARS-CoV-2 genome.
The COVIDSeq Test (RUO Version) is intended for the NovaSeq 6000 Sequencing System. It can also be run on the iSeq 100, MiniSeq, MiSeq, MiSeqDx in Research Mode, NextSeq 500, NextSeq 550, NextSeq 550Dx in Research Mode, NextSeq 1000, or NextSeq 2000 Systems.
The primary difference is the number of samples each assay can run. The COVIDSeq Assay (96 samples) runs 96 samples on Illumina benchtop sequencing systems to accommodate smaller research labs. In contrast, the COVIDSeq Test (RUO) runs up to 3072 samples on the NovaSeq 6000 System or NextSeq line of sequencing systems.
As SARS-CoV-2 mutates, updates to the primer pools are occasionally necessary to ensure complete coverage across the genome and improved analytical sensitivity for SARS-CoV-2 variant detection. The v5.4.2 primers provide increased coverage for recent Omicron variants.
Advanced chemistry, optics, and informatics combine to deliver exceptional speed and data quality, outstanding throughput and scalability.
Optimized reagent kit that provides increased cluster density and read length, improving sequencing quality scores compared to earlier versions.
Enable CGP with a large pan-cancer panel covering all major variant classes plus gene signatures (TMB, MSI, and HRD) from FFPE tissue.
A fast, integrated workflow for preparing libraries for use in a wide range of sequencing applications.
This low- to mid-throughput NGS assay enables labs of any size to identify and track the emergence and prevalence of novel SARS-CoV-2 variants.
Library prep and enrichment kit that delivers highly sensitive, comprehensive respiratory pathogen identification and antimicrobial resistance insights.
This panel supports characterization and genomic surveillance of 225 known and novel coronaviruses from humans and animal reservoirs.
Interested in bringing the Illumina COVIDSeq Test into your lab for surveillance applications?
Your email address is never shared with third parties.
